GENVID HOLDINGS, INC. – Trademark Portfolio
Entity Type: 03
GENVID HOLDINGS, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include GENVID. The owner is based in NEW YORK, NY.
1325 6TH AVE
SUITE 2822
NEW YORK, NY 10019
Showing of trademarks Trademarks
Trademark Classifications
GENVID HOLDINGS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GENVID HOLDINGS, INC. have?
GENVID HOLDINGS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does GENVID HOLDINGS, INC. file in?
GENVID HOLDINGS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 38 (Telecommunications), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are GENVID HOLDINGS, INC.'s most well-known trademarks?
GENVID HOLDINGS, INC.'s registered trademark portfolio includes well-known marks such as GENVID. These are among 6 currently registered trademarks in the portfolio.
What is GENVID HOLDINGS, INC.'s trademark registration success rate?
GENVID HOLDINGS, INC. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.